https://stock.noler.com/us/stock/immunoclin-corp https://stock.noler.com/us/stock/immunoclin-corp/accounts-payable https://stock.noler.com/us/stock/immunoclin-corp/accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/immunoclin-corp/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/immunoclin-corp/accounts-receivable https://stock.noler.com/us/stock/immunoclin-corp/accrued-liabilities-for-commissions-expense-and-taxes https://stock.noler.com/us/stock/immunoclin-corp/additional-paid-in-capital https://stock.noler.com/us/stock/immunoclin-corp/amortization https://stock.noler.com/us/stock/immunoclin-corp/aoci https://stock.noler.com/us/stock/immunoclin-corp/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/immunoclin-corp/capital-expenditures https://stock.noler.com/us/stock/immunoclin-corp/cash https://stock.noler.com/us/stock/immunoclin-corp/cash-and-equivalents https://stock.noler.com/us/stock/immunoclin-corp/cash-change https://stock.noler.com/us/stock/immunoclin-corp/cash-flow-breakdown https://stock.noler.com/us/stock/immunoclin-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/immunoclin-corp/common-stock-value https://stock.noler.com/us/stock/immunoclin-corp/comprehensive-income https://stock.noler.com/us/stock/immunoclin-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/immunoclin-corp/current-assets https://stock.noler.com/us/stock/immunoclin-corp/current-liabilities https://stock.noler.com/us/stock/immunoclin-corp/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/immunoclin-corp/debt-decrease-forgiveness https://stock.noler.com/us/stock/immunoclin-corp/debt-increase-decrease-other-net https://stock.noler.com/us/stock/immunoclin-corp/deferred-revenue https://stock.noler.com/us/stock/immunoclin-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/immunoclin-corp/deposit-assets https://stock.noler.com/us/stock/immunoclin-corp/depreciation https://stock.noler.com/us/stock/immunoclin-corp/depreciation-and-amortization https://stock.noler.com/us/stock/immunoclin-corp/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/immunoclin-corp/due-to-related-parties https://stock.noler.com/us/stock/immunoclin-corp/due-to-related-parties-current https://stock.noler.com/us/stock/immunoclin-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/immunoclin-corp/effective-tax-rate https://stock.noler.com/us/stock/immunoclin-corp/financing-cash-flow https://stock.noler.com/us/stock/immunoclin-corp/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/immunoclin-corp/finite-lived-intangible-assets-fair-value-disclosure https://stock.noler.com/us/stock/immunoclin-corp/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/immunoclin-corp/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/immunoclin-corp/general-and-administrative-expense https://stock.noler.com/us/stock/immunoclin-corp/goodwill https://stock.noler.com/us/stock/immunoclin-corp/income-tax https://stock.noler.com/us/stock/immunoclin-corp/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/immunoclin-corp/income-tax-credits-and-adjustments https://stock.noler.com/us/stock/immunoclin-corp/income-taxes-paid https://stock.noler.com/us/stock/immunoclin-corp/income-taxes-paid-2 https://stock.noler.com/us/stock/immunoclin-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/immunoclin-corp/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/immunoclin-corp/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/immunoclin-corp/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/immunoclin-corp/increase-decrease-in-deposits https://stock.noler.com/us/stock/immunoclin-corp/increase-decrease-in-due-to-related-parties-current https://stock.noler.com/us/stock/immunoclin-corp/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/immunoclin-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/immunoclin-corp/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/immunoclin-corp/insider-transactions-preferred https://stock.noler.com/us/stock/immunoclin-corp/insider-transactions-preferred/sales https://stock.noler.com/us/stock/immunoclin-corp/insider-transactions-stock-options https://stock.noler.com/us/stock/immunoclin-corp/interest-expense https://stock.noler.com/us/stock/immunoclin-corp/interest-paid https://stock.noler.com/us/stock/immunoclin-corp/investing-cash-flow https://stock.noler.com/us/stock/immunoclin-corp/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/immunoclin-corp/liabilities-assumed https://stock.noler.com/us/stock/immunoclin-corp/management-fee-expense https://stock.noler.com/us/stock/immunoclin-corp/marketable-securities-gain-loss https://stock.noler.com/us/stock/immunoclin-corp/marketable-securities-noncurrent https://stock.noler.com/us/stock/immunoclin-corp/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/immunoclin-corp/net-change-in-cash https://stock.noler.com/us/stock/immunoclin-corp/net-income https://stock.noler.com/us/stock/immunoclin-corp/new-shares-sold https://stock.noler.com/us/stock/immunoclin-corp/notes-assumed https://stock.noler.com/us/stock/immunoclin-corp/notes-payable-current https://stock.noler.com/us/stock/immunoclin-corp/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/immunoclin-corp/notes-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/immunoclin-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/immunoclin-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/immunoclin-corp/operating-cash-flow https://stock.noler.com/us/stock/immunoclin-corp/operating-expenses https://stock.noler.com/us/stock/immunoclin-corp/operating-income https://stock.noler.com/us/stock/immunoclin-corp/operating-loss-carryforwards https://stock.noler.com/us/stock/immunoclin-corp/other-income https://stock.noler.com/us/stock/immunoclin-corp/other-noncash-expense https://stock.noler.com/us/stock/immunoclin-corp/other-receivables-net-current https://stock.noler.com/us/stock/immunoclin-corp/paid-in-capital-other https://stock.noler.com/us/stock/immunoclin-corp/preferred-shares-facts https://stock.noler.com/us/stock/immunoclin-corp/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/immunoclin-corp/preferred-stock-shares-authorized https://stock.noler.com/us/stock/immunoclin-corp/preferred-stock-shares-issued https://stock.noler.com/us/stock/immunoclin-corp/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/immunoclin-corp/preferred-stock-value https://stock.noler.com/us/stock/immunoclin-corp/prepaid-expense-current https://stock.noler.com/us/stock/immunoclin-corp/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/immunoclin-corp/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/immunoclin-corp/proceeds-from-notes-payable https://stock.noler.com/us/stock/immunoclin-corp/proceeds-from-payments-for-long-term-loans-for-related-parties https://stock.noler.com/us/stock/immunoclin-corp/proceeds-from-related-party-debt https://stock.noler.com/us/stock/immunoclin-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/immunoclin-corp/professional-and-contract-services-expense https://stock.noler.com/us/stock/immunoclin-corp/professional-fees https://stock.noler.com/us/stock/immunoclin-corp/profit-loss https://stock.noler.com/us/stock/immunoclin-corp/property-plant-equipment https://stock.noler.com/us/stock/immunoclin-corp/public-float https://stock.noler.com/us/stock/immunoclin-corp/repayments-of-notes-payable https://stock.noler.com/us/stock/immunoclin-corp/repayments-of-related-party-debt https://stock.noler.com/us/stock/immunoclin-corp/research-and-development https://stock.noler.com/us/stock/immunoclin-corp/retained-earnings https://stock.noler.com/us/stock/immunoclin-corp/revenue https://stock.noler.com/us/stock/immunoclin-corp/sale-of-stock-price-per-share https://stock.noler.com/us/stock/immunoclin-corp/shareholders-equity https://stock.noler.com/us/stock/immunoclin-corp/shares-authorized https://stock.noler.com/us/stock/immunoclin-corp/shares-issued https://stock.noler.com/us/stock/immunoclin-corp/shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/immunoclin-corp/shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/immunoclin-corp/stock-based-compensation https://stock.noler.com/us/stock/immunoclin-corp/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/immunoclin-corp/stock-issued-shares-issued-value-issued-for-noncash-considerations https://stock.noler.com/us/stock/immunoclin-corp/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/immunoclin-corp/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/immunoclin-corp/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/immunoclin-corp/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/immunoclin-corp/stock-options-outstanding-number https://stock.noler.com/us/stock/immunoclin-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/immunoclin-corp/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/immunoclin-corp/tax-reconciliation-nondeductible-expense-depreciation-and-amortization https://stock.noler.com/us/stock/immunoclin-corp/tax-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/immunoclin-corp/tax-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/immunoclin-corp/technology-services-costs https://stock.noler.com/us/stock/immunoclin-corp/total-assets https://stock.noler.com/us/stock/immunoclin-corp/total-liabilities https://stock.noler.com/us/stock/immunoclin-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/immunoclin-corp/translation-adjustment-functional-to-reporting-currency-net-of-tax https://stock.noler.com/us/stock/immunoclin-corp/unrecognized-tax-benefits https://stock.noler.com/us/stock/immunoclin-corp/weighted-average-number-of-share-outstanding-basic-and-diluted